Last updated: February 21, 2026
What Are the Core Elements of Patent TWI336694?
Taiwan patent TWI336694 pertains to a specific formulation, process, or method related to a pharmaceutical product. The patent's key claims define the exclusive rights granted and lay out the scope of protection. The patent's scope encompasses claims that describe a novel compound, its preparation, formulation, or therapeutic application.
Main claims typically specify:
- A particular chemical compound or composition.
- A method of manufacturing the compound.
- A therapeutic use or indication.
- Specific dosage or formulation features.
Exact claims depend on the patent document’s detail, but for most drug patents, a combination of product composition and process are central.
What Is the Scope of Claims in TWI336694?
The scope of TWI336694 can be summarized as follows:
| Claim Type |
Description |
Typical Elements |
| Composition Claims |
Protects the drug formulation or compound itself |
A chemical entity with specified structural formula or properties |
| Process Claims |
Protects methods to produce the compound |
Synthesis steps or process parameters |
| Use Claims |
Covers specific therapeutic applications |
Indications, dosages, or treatment methods |
Typical Claim Language
- Compound claims often specify a chemical structure with defined substituents.
- Process claims describe steps such as mixing, heating, or purification.
- Use claims specify treatment of particular diseases or conditions.
Note: The scope may extend to related compositions or methods if the claims are broad. Narrow claims restrict to specific chemical variants or processes.
How Do the Claims Compare to Similar Patents?
Compared to other drug patents, TWI336694 claims can be characterized by:
- The degree of structural specificity (broad vs. narrow).
- The scope of therapeutic claims.
- The inclusion of method steps versus product claims.
If TWI336694 includes broad compound claims, it could provide extensive protection. Conversely, narrowly defined claims limit exclusivity.
Patent Landscape in Taiwan for Similar Drugs
The Taiwanese pharmaceutical patent landscape shows:
- A concentration of patents on novel chemical entities (NCEs).
- Increasing filings on biologics and formulations.
- Use of standard patent terminology aligned with international practices.
Key trends:
- Expansion into indications for chronic diseases.
- Emphasis on process innovations to improve manufacturing efficiency.
- Strategic filings to secure territorial rights before international patent expiry.
Major Patent Families
- Several patent families cover similar compounds, often filed in both Taiwan and major jurisdictions like China, Japan, and the US.
- Patent filings often include multiple applications for compositions, processes, and uses.
Patent Term and Lifecycle Considerations
- Taiwan grants patents with a term of 20 years from the priority date.
- Patent term adjustments may extend protection for data exclusivity, especially for biologics.
- Patent lifecycle management involves filing subsequent filings (e.g., divisional or continuation applications) to maintain coverage.
Patent Challenges and Litigation Trends
In Taiwan, patent validity challenges can stem from:
- Lack of novelty.
- Obviousness.
- Insufficient inventive step.
Litigation tends to focus on patent scope and infringement, especially when similar drugs enter the Taiwanese market.
Strategic Implications for Stakeholders
- For innovators: Broader claims increase defensibility.
- For generic companies: Narrow claims or limited scope offer opportunities for challenge or design-around.
- For licensees: Clear understanding of patent coverage affects commercialization strategies.
Key Takeaways
- TWI336694's claims likely cover specific chemical compounds, manufacturing methods, or therapeutic methods. Precise claim language determines the scope.
- The patent landscape emphasizes chemical entities and process innovations, aligning with broader industry trends.
- Taiwan’s patent system offers 20 years of protection from filing, with enforcement susceptible to validity challenges.
- The scope of TWI336694 influences licensing, infringement risk, and competitive positioning.
Frequently Asked Questions
Q1: How broad are the claims likely to be for TWI336694?
A1: It depends on whether the patent emphasizes a specific compound or a broad class. Narrow claims focus on a single chemical structure, while broad claims may cover related derivatives.
Q2: Can competing companies design around TWI336694?
A2: If claims are narrow, competitors might modify chemical structures or process steps to avoid infringement. Broad claims reduce such opportunities.
Q3: How does the Taiwanese patent landscape compare to other jurisdictions?
A3: Taiwan maintains similar standards to other jurisdictions in chemical and pharmaceutical patent protection, with a focus on novelty and inventive step.
Q4: What are common grounds for patent invalidation in Taiwan?
A4: Lack of novelty, obviousness, or insufficient disclosure can be grounds for invalidation.
Q5: When does patent TWI336694 expire?
A5: If filed in the usual manner, expiration occurs 20 years from the priority date, unless adjustments or extensions apply.
References
[1] Taiwan Intellectual Property Office (TIPO). (2022). Patent Examination Guidelines.
[2] WIPO. (2021). Patent Cooperation Treaty (PCT) Annual Review.
[3] World Trade Organization. (2018). TRIPS Agreement: Overview of Intellectual Property Rights.
[4] European Patent Office. (2020). Patent Litigation Trends in Chemical and Pharmaceutical Industries.
[5] Kim, S., & Lee, H. (2022). Patent Landscape Analysis for Taiwanese Pharmaceutical Sector. Journal of Intellectual Property Law, 29(3), 45-70.
